Anbio Biotechnology Class A Ordinary Shares

Healthcare

NASDAQ:NNNN · NASDAQ Global Select

Market Cap $730.35M Beta 4.34 P/E (TTM) 99.1

$16.64 +2.30%

+$0.37 today

52W Low $10.50High $55.65

Vol 0.02M · Avg 0.03M

EPS (TTM) $0.16Medical - Instruments & Supplies

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-11.72%

Period High

$52.10

Period Low

$12.29

Latest

$16.64

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

KalVista Pharmaceuticals, Inc.

NASDAQ:KALV

$1.44B

Avanos Medical, Inc.

NYSE:AVNS

$1.17B

COMPASS Pathways plc

NASDAQ:CMPS

$1.16B

Talkspace, Inc.

NASDAQ:TALK

$872.74M

Rigel Pharmaceuticals, Inc.

NASDAQ:RIGL

$604.74M

ClearPoint Neuro, Inc.

NASDAQ:CLPT

$537.11M

AngioDynamics, Inc.

NASDAQ:ANGO

$492.52M

Community Health Systems, Inc.

NYSE:CYH

$429.09M

SNDL Inc.

NASDAQ:SNDL

$367.05M

Gossamer Bio, Inc.

GOSS

$39.12M

What is the latest NNNN filing?

The latest filing shown is 3 dated Jun 12, 2026.

How many recent filings does NNNN have?

Intrinsic Alpha currently shows 20 recent filings for NNNN.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.